Table 1.
Stage I Developmental arrest (typically in children 6–18 months of age) |
Stage II Rapid deterioration or regression (typically in children 1–4 years of age) |
Stage III Pseudostationary (typically in children 2–10 years of age) |
Stage IV Late motor deterioration (typically in patients > 10 years) |
---|---|---|---|
Benign congenital hypotonia | Autism | Spastic ataxia | Other degenerative disorders |
Cerebral palsy | Angelman syndrome | Cerebral palsy | |
Prader–Willi syndrome | Encephalitis | Spinocerebellar | |
Metabolic disorders (e.g., fetal alcohol syndrome, trisomy 13) | Hearing and/or visual disturbance | degeneration | |
Landau–Kleffner syndrome | Leukodystrophies | ||
Psychoses | Neuroaxonal dystrophy | ||
Slow virus | Lennox–Gastaut syndrome | ||
Panencephalopathy | Angelman syndrome (likely not Kabuki because patients would have macrocephaly) | ||
Tuberous sclerosis | |||
Metabolic disorders (e.g., phenylketonuria, ornithine transcarbamylase deficiency) | |||
Infantile neuronal ceroid lipofuscinosis |